CD247, a Potential T Cell–Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis

BackgroundIdiopathic pulmonary fibrosis (IPF) has high mortality worldwide. The CD247 molecule (CD247, as known as T-cell surface glycoprotein CD3 zeta chain) has been reported as a susceptibility locus in systemic sclerosis, but its correlation with IPF remains unclear.MethodsDatasets were acquired...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yupeng Li, Shibin Chen, Xincheng Li, Xue Wang, Huiwen Li, Shangwei Ning, Hong Chen
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/0cade99219af45408e99c8f016a4486c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0cade99219af45408e99c8f016a4486c
record_format dspace
spelling oai:doaj.org-article:0cade99219af45408e99c8f016a4486c2021-11-22T06:38:19ZCD247, a Potential T Cell–Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis1664-322410.3389/fimmu.2021.762594https://doaj.org/article/0cade99219af45408e99c8f016a4486c2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.762594/fullhttps://doaj.org/toc/1664-3224BackgroundIdiopathic pulmonary fibrosis (IPF) has high mortality worldwide. The CD247 molecule (CD247, as known as T-cell surface glycoprotein CD3 zeta chain) has been reported as a susceptibility locus in systemic sclerosis, but its correlation with IPF remains unclear.MethodsDatasets were acquired by researching the Gene Expression Omnibus (GEO). CD247 was identified as the hub gene associated with percent predicted diffusion capacity of the lung for carbon monoxide (Dlco% predicted) and prognosis according to Pearson correlation, logistic regression, and survival analysis.ResultsCD247 is significantly downregulated in patients with IPF compared with controls in both blood and lung tissue samples. Moreover, CD247 is significantly positively associated with Dlco% predicted in blood and lung tissue samples. Patients with low-expression CD247 had shorter transplant-free survival (TFS) time and more composite end-point events (CEP, death, or decline in FVC >10% over a 6-month period) compared with patients with high-expression CD247 (blood). Moreover, in the follow-up 1st, 3rd, 6th, and 12th months, low expression of CD247 was still the risk factor of CEP in the GSE93606 dataset (blood). Thirteen genes were found to interact with CD247 according to the protein–protein interaction network, and the 14 genes including CD247 were associated with the functions of T cells and natural killer (NK) cells such as PD-L1 expression and PD-1 checkpoint pathway and NK cell-mediated cytotoxicity. Furthermore, we also found that a low expression of CD247 might be associated with a lower activity of TIL (tumor-infiltrating lymphocytes), checkpoint, and cytolytic activity and a higher activity of macrophages and neutrophils.ConclusionThese results imply that CD247 may be a potential T cell-derived disease severity and prognostic biomarker for IPF.Yupeng LiShibin ChenXincheng LiXue WangHuiwen LiShangwei NingHong ChenFrontiers Media S.A.articleidiopathic pulmonary fibrosisCD247immune responseinflammation responsebiomarkerprognosisImmunologic diseases. AllergyRC581-607ENFrontiers in Immunology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic idiopathic pulmonary fibrosis
CD247
immune response
inflammation response
biomarker
prognosis
Immunologic diseases. Allergy
RC581-607
spellingShingle idiopathic pulmonary fibrosis
CD247
immune response
inflammation response
biomarker
prognosis
Immunologic diseases. Allergy
RC581-607
Yupeng Li
Shibin Chen
Xincheng Li
Xue Wang
Huiwen Li
Shangwei Ning
Hong Chen
CD247, a Potential T Cell–Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis
description BackgroundIdiopathic pulmonary fibrosis (IPF) has high mortality worldwide. The CD247 molecule (CD247, as known as T-cell surface glycoprotein CD3 zeta chain) has been reported as a susceptibility locus in systemic sclerosis, but its correlation with IPF remains unclear.MethodsDatasets were acquired by researching the Gene Expression Omnibus (GEO). CD247 was identified as the hub gene associated with percent predicted diffusion capacity of the lung for carbon monoxide (Dlco% predicted) and prognosis according to Pearson correlation, logistic regression, and survival analysis.ResultsCD247 is significantly downregulated in patients with IPF compared with controls in both blood and lung tissue samples. Moreover, CD247 is significantly positively associated with Dlco% predicted in blood and lung tissue samples. Patients with low-expression CD247 had shorter transplant-free survival (TFS) time and more composite end-point events (CEP, death, or decline in FVC >10% over a 6-month period) compared with patients with high-expression CD247 (blood). Moreover, in the follow-up 1st, 3rd, 6th, and 12th months, low expression of CD247 was still the risk factor of CEP in the GSE93606 dataset (blood). Thirteen genes were found to interact with CD247 according to the protein–protein interaction network, and the 14 genes including CD247 were associated with the functions of T cells and natural killer (NK) cells such as PD-L1 expression and PD-1 checkpoint pathway and NK cell-mediated cytotoxicity. Furthermore, we also found that a low expression of CD247 might be associated with a lower activity of TIL (tumor-infiltrating lymphocytes), checkpoint, and cytolytic activity and a higher activity of macrophages and neutrophils.ConclusionThese results imply that CD247 may be a potential T cell-derived disease severity and prognostic biomarker for IPF.
format article
author Yupeng Li
Shibin Chen
Xincheng Li
Xue Wang
Huiwen Li
Shangwei Ning
Hong Chen
author_facet Yupeng Li
Shibin Chen
Xincheng Li
Xue Wang
Huiwen Li
Shangwei Ning
Hong Chen
author_sort Yupeng Li
title CD247, a Potential T Cell–Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis
title_short CD247, a Potential T Cell–Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis
title_full CD247, a Potential T Cell–Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis
title_fullStr CD247, a Potential T Cell–Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis
title_full_unstemmed CD247, a Potential T Cell–Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis
title_sort cd247, a potential t cell–derived disease severity and prognostic biomarker in patients with idiopathic pulmonary fibrosis
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/0cade99219af45408e99c8f016a4486c
work_keys_str_mv AT yupengli cd247apotentialtcellderiveddiseaseseverityandprognosticbiomarkerinpatientswithidiopathicpulmonaryfibrosis
AT shibinchen cd247apotentialtcellderiveddiseaseseverityandprognosticbiomarkerinpatientswithidiopathicpulmonaryfibrosis
AT xinchengli cd247apotentialtcellderiveddiseaseseverityandprognosticbiomarkerinpatientswithidiopathicpulmonaryfibrosis
AT xuewang cd247apotentialtcellderiveddiseaseseverityandprognosticbiomarkerinpatientswithidiopathicpulmonaryfibrosis
AT huiwenli cd247apotentialtcellderiveddiseaseseverityandprognosticbiomarkerinpatientswithidiopathicpulmonaryfibrosis
AT shangweining cd247apotentialtcellderiveddiseaseseverityandprognosticbiomarkerinpatientswithidiopathicpulmonaryfibrosis
AT hongchen cd247apotentialtcellderiveddiseaseseverityandprognosticbiomarkerinpatientswithidiopathicpulmonaryfibrosis
_version_ 1718418084497195008